Sponsor Pipeline

Ribotek Biopharmaceuticals (Shandong) Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07587788 RBD5044 in Chinese Participants With Hypertriglyceridemia Hypertriglyceridemia Recruiting
Get alerts when Ribotek Biopharmaceuticals (Shandong) Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free